The emerging treatment of tirzepatide peptide represents a major development in the handling of type 2 diabetes. Distinct from existing medications, tirzepatide targets dual pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide411350.blogdomago.com/40470886/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment